| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/31/2013 | CN102349871B Nano-micro drug delivery system and preparation method of 10-hydroxyl camptothecin |
| 07/31/2013 | CN102327619B Polyethyleneglycol surface self-assembly gold-base nano antioxidant, preparation method and application thereof |
| 07/31/2013 | CN102321178B Novel gonadotropin releasing hormone oriented fusion protein mutant |
| 07/31/2013 | CN102283799B Azithromycin gel eye drops and preparation process thereof |
| 07/31/2013 | CN102276456B Process for preparing pharmaceutical excipient mixed fatty acid glyceride |
| 07/31/2013 | CN102271713B Neurotensin-derived branched peptides and uses thereof |
| 07/31/2013 | CN102225996B Preparation method for benzoxazine resin nano-polymer sphere and benzoxazine resin nano-polymer carbon sphere |
| 07/31/2013 | CN102210646B Human rabies vaccine gel and preparation method thereof |
| 07/31/2013 | CN102205129B Novel nasal mucosa absorption enhancer |
| 07/31/2013 | CN101959505B Improved isomalt-containing tablets and methods for the production thereof |
| 07/31/2013 | CN101897756B Preparation method of silver yellow medicinal preparation containing polyethylene glycol 12-hydroxy stearate |
| 07/31/2013 | CN101875508B Preparation method of Fe3O4 nano-magnetic powder lymphatic tracer and application thereof |
| 07/31/2013 | CN101854814B Method of improving sweetness qualities of stevia extract |
| 07/31/2013 | CN101756954B Schneiderian membrane medication preparation of isosorbide dinitrate and preparation method thereof |
| 07/31/2013 | CN101618027B Aceclofenac bi-layer osmotic pump controlled release tablets and preparation method thereof |
| 07/31/2013 | CN101559229B Inhalative and instillative use of semi-fluorised alkanes as active ingredient carriers in the intrapulmonary area |
| 07/31/2013 | CN101537189B Aptamer and new use of derivative thereof |
| 07/31/2013 | CN101502490B Ketoprofen bioadhesive gel microsphere and preparation method thereof |
| 07/31/2013 | CN101412742B Nitric acid ester medicament for inhibiting angiogenesis |
| 07/31/2013 | CN101404995B Lignane compound-containing oil-in-water emulsion and composition comprising the same |
| 07/30/2013 | US8497398 Polyamine transporter selective compounds as anti-cancer agents |
| 07/30/2013 | US8497388 Phospholipid-analogous compounds |
| 07/30/2013 | US8497357 Degradable heterobifunctional poly(ethylene glycol) acrylates and gels and conjugates derived therefrom |
| 07/30/2013 | US8497351 Nucleic acid and corresponding protein entitled 162P1E6 useful in treatment and detection of cancer |
| 07/30/2013 | US8497304 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
| 07/30/2013 | US8497303 Method to enhance aqueous solubility of poorly soluble actives |
| 07/30/2013 | US8497237 Compositions comprising enzyme-cleavable oxycodone prodrug |
| 07/30/2013 | US8496965 Pellet formulation for the treatment of the intenstinal tract |
| 07/30/2013 | US8496961 Delivery of nucleic acid-like compounds |
| 07/30/2013 | US8496958 Compositions and methods for the sustained release of beta-alanine |
| 07/30/2013 | US8496954 Coating systems for the controlled delivery of hydrophilic bioactive agents |
| 07/30/2013 | US8496939 An adjuvant is used in vaccine formulation, comprising a polymeric emulsifier Arlacel" or ATLOX"; stable, low viscosity |
| 07/30/2013 | US8496930 Method of stabilizing antibody and stabilized solution-type antibody preparation |
| 07/30/2013 | CA2742361C Highly purified polylactic acid or a derivative thereof, a salt of the same, and purification method thereof |
| 07/30/2013 | CA2700983C Composition and method of stabilized sensitive ingredient |
| 07/30/2013 | CA2645058C Pharmaceutical composition for external use |
| 07/30/2013 | CA2611823C Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates |
| 07/30/2013 | CA2589889C Therapeutic formulations of keratinocyte growth factor |
| 07/30/2013 | CA2581487C Isocyclomaltooligosaccharide (s), isocyclomaltooligosaccharide-forming enzyme, their preparation and uses |
| 07/30/2013 | CA2580397C Aqueous pharmaceutical preparation comprising roflumilast and an alkoxylated fat |
| 07/30/2013 | CA2551510C Stable growth hormone liquid formulation |
| 07/30/2013 | CA2513213C Albumin fusion proteins |
| 07/30/2013 | CA2503630C Improved formulations containing substituted imidazole derivatives |
| 07/30/2013 | CA2483917C Formulations limiting spread of pulmonary infections |
| 07/30/2013 | CA2463158C Depot formulations of iloperidone and a star polymer |
| 07/30/2013 | CA2462886C Flashmelt oral dosage formulation |
| 07/27/2013 | CA2861932A1 Chromatographic media for storage and delivery of therapeutic biologics and small molecules |
| 07/25/2013 | WO2013110056A1 Biomaterials comprising hyaluronic acid binding peptides and bifunctional biopolymer molecules for hyaluronic acid retention and tissue engineering applications |
| 07/25/2013 | WO2013110028A1 Nanoparticle formulations with enhanced mucosal penetration |
| 07/25/2013 | WO2013109994A1 Surrobody cojugates |
| 07/25/2013 | WO2013109983A1 High molecular wieght arginine-grafted bioreducible polymers |
| 07/25/2013 | WO2013109939A1 Methods of making and using nanostructures |
| 07/25/2013 | WO2013109832A1 Stable colloidal suspensions of gold nanoconjugates and the method for preparing the same |
| 07/25/2013 | WO2013109825A1 Chromatographic media for storage and delivery of therapeutic biologics and small molecules |
| 07/25/2013 | WO2013109811A1 Human placental derived extracellular matrix and uses thereof |
| 07/25/2013 | WO2013109675A2 Compositions and methods for treating cancer and inflammation-related diseases and conditions |
| 07/25/2013 | WO2013109057A1 Magnetic nanoparticle-samirna complex and method for preparing same |
| 07/25/2013 | WO2013108991A1 Biocompatible particles and method for preparing same |
| 07/25/2013 | WO2013108983A1 Ph-reactive high-density lipoprotein-like particle complex |
| 07/25/2013 | WO2013108180A1 Aqueous paracetamol composition for injection |
| 07/25/2013 | WO2013107810A1 Transmucosal administration system for a pharmaceutical drug |
| 07/25/2013 | WO2013107515A1 Eye drop composition |
| 07/25/2013 | WO2013107427A1 Therapeutic compositions for intranasal administration of zolpidem |
| 07/25/2013 | WO2013107388A1 Interferon and immune globulin fc section fusion protein |
| 07/25/2013 | WO2013107236A1 Crystal form of (6s)-5-methyltetrahydrofolate salt and method for preparing same |
| 07/25/2013 | WO2013106909A1 Novel peptides and methods and uses thereof for preventing retinal disorders |
| 07/25/2013 | WO2013068946A3 Antibodies specific for trop-2 and their uses |
| 07/25/2013 | US20130190839 Drug delivery using a sacrificial host |
| 07/25/2013 | US20130190724 Prevention of indwelling device related infection: composition and methods |
| 07/25/2013 | US20130190494 Purine analogs |
| 07/25/2013 | US20130190475 Drug-ligand conjugates, synthesis thereof, and intermediates thereto |
| 07/25/2013 | US20130190450 Cyclodextrin-based polymers for therapeutics delivery |
| 07/25/2013 | US20130190410 Novel polymeric thickening agent free of acrylamide fragments, method for the preparation thereof, and composition containing same |
| 07/25/2013 | US20130190409 Drug delivery vehicles, methods of manufacture, and methods of use thereof |
| 07/25/2013 | US20130190401 Veterinary dermatologic composition |
| 07/25/2013 | US20130190372 Bendamustine cyclopolysaccharide compositions |
| 07/25/2013 | US20130190349 Therapeutic compositions for intranasal administration of zolpidem |
| 07/25/2013 | US20130190324 Topical ocular drug delivery |
| 07/25/2013 | US20130190277 Paraffin Wax Embedded Drug Delivery System |
| 07/25/2013 | US20130190252 Pharmaceutical formulation containing lipophilic drugs and milk as a solubilizing/dispensing agent and method for the preparation thereof |
| 07/25/2013 | US20130190232 N-terminal modified fgf21 compounds |
| 07/25/2013 | US20130189519 Drug and Imaging Agent Delivery Compositions and Methods |
| 07/25/2013 | US20130189372 Topical antibiotic formulations |
| 07/25/2013 | US20130189356 Pellet formulation for the treatment of the intestinal tract |
| 07/25/2013 | US20130189349 Sustained-release liposomal anesthetic compositions |
| 07/25/2013 | US20130189326 Method for controlling toxicity of metallic particle and low-toxicity composite of metallic nanoparticle and inorganic clay |
| 07/25/2013 | US20130189325 Methods of applying coating materials for solid medicines |
| 07/25/2013 | US20130189322 Chromatographic Media for Storage and Delivery of Therapeutic Biologics and Small Molecules |
| 07/25/2013 | US20130189304 Preservation of bioactive materials by freeze dried foam |
| 07/25/2013 | US20130189286 Antibody drug conjugates (adc) that bind to 191p4d12 proteins |
| 07/25/2013 | US20130189277 Stabilized Formulations Containing Anti-PCSK9 Antibodies |
| 07/25/2013 | US20130189230 Injectable polymer composition for use as a cell delivery vehicle |
| 07/25/2013 | US20130189219 N-terminally chemically modified protein compositions and methods |
| 07/25/2013 | US20130189218 Pharmaceutical formulations for fumagillin derivative-phf conjugates |
| 07/25/2013 | US20130189198 Acrylate Copolymer Thickeners |
| 07/25/2013 | US20130189197 Long-chain oxyaminopolyol based gelator and gel |
| 07/25/2013 | US20130189193 Foamable Vehicle and Pharmaceutical Compositions Thereof |
| 07/25/2013 | DE112011103342T5 Stickstoffoxid-Abgabesysteme unter Verwendung von wärmeempfindlichen svnthetischen Polymeren The nitric oxide delivery systems using thermosensitive polymers svnthetischen |
| 07/25/2013 | CA2863500A1 Eye drop composition |
| 07/24/2013 | EP2617812A1 Composition for maintaining platelet function |